/ Unknown statusNot Applicable Open-label Trial to Assess the Efficacy and Safety of Inhalation Use of the Approved Drug Surfactant-BL (Biosurf LLC, Russia) as a Part of Complex Therapy of Acute Respiratory Distress Syndrome (ARDS) in Patients With SARS-CoV-2 Coronavirus Infection (COVID-19)
The purpose of this study is to prove the efficacy and safety Surfactant-BL, administered by inhalation in adult hospitalized patients with ARDS due to COVID-19.
100 Clinical Results associated with Biosurf OOO
0 Patents (Medical) associated with Biosurf OOO
100 Deals associated with Biosurf OOO
100 Translational Medicine associated with Biosurf OOO